Identifying Adverse Events in Outpatients With Prostate Cancer Using Pharmaceutical Care Records in Community Pharmacies: Application of Named Entity Recognition

Identifying Adverse Events in Outpatients With Prostate Cancer Using Pharmaceutical Care Records in Community Pharmacies: Application of Named Entity Recognition

BackgroundAndrogen receptor axis-targeting reagents (ARATs) have become key drugs for patients with castration-resistant prostate cancer (CRPC). ARATs are taken long term in outpatient settings, and effective adverse event (AE) monitoring can help prolong treatment duration f...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuki Yanagisawa, Satoshi Watabe, Sakura Yokoyama, Kyoko Sayama, Hayato Kizaki, Masami Tsuchiya, Shungo Imai, Mitsuhiro Someya, Ryoo Taniguchi, Shuntaro Yada, Eiji Aramaki, Satoko Hori
Format: Article
Language:English
Published: JMIR Publications 2025-03-01
Series:JMIR Cancer
Online Access:https://cancer.jmir.org/2025/1/e69663
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://cancer.jmir.org/2025/1/e69663

Similar Items